Literature DB >> 15752579

CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats.

Jian-Fen Xu1, Xue-Qun Chen, Ji-Zeng Du, Tong-Ying Wang.   

Abstract

We demonstrated previously that hypoxia activated CRF and CRF mRNA in PVN, and CRF receptor 1 (CRFR1) mRNA in rat pituitary. The aim of the study is to test whether the hypoxia-activated CRF and CRF mRNA is associated with triggering CRFR1. Rats were exposed to hypobaric hypoxia at altitude of 2 and 5 km. CRF and CRF mRNA were assayed by immunostaining and in situ hybridization. CRFR1 mRNA was assayed by RT-PCR. Results showed that 5 km continual hypoxia increased CRF and CRF mRNA in PVN, CRFR1 mRNA in pituitary, and plasma corticosterone. The hypoxia-increased CRF, CRF mRNA, CRFR1 mRNA, and corticosterone were blocked by CRFR1 antagonist (CP-154,526), suggesting that CRFR1 in PVN and pituitary are responsible for the hypoxia-increased CRF and CRF mRNA in PVN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752579     DOI: 10.1016/j.peptides.2004.11.014

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice.

Authors:  J R Fee; D R Sparta; M J Picker; T E Thiele
Journal:  Neuroscience       Date:  2007-09-08       Impact factor: 3.590

2.  Overactivation of corticotropin-releasing factor receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema.

Authors:  Shao-Jun Chen; Jia-Fang Yang; Fan-Ping Kong; Ji-Long Ren; Ke Hao; Min Li; Yuan Yuan; Xin-Can Chen; Ri-Sheng Yu; Jun-Fa Li; Gareth Leng; Xue-Qun Chen; Ji-Zeng Du
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-21       Impact factor: 11.205

3.  Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma.

Authors:  Yongji Yan; Chao Wang; Yiqin Lu; Huijie Gong; Zhun Wu; Xin Ma; Hongzhao Li; Baojun Wang; Xu Zhang
Journal:  J Physiol Biochem       Date:  2017-11-21       Impact factor: 4.158

4.  Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures.

Authors:  Dennis R Sparta; Angela M Sparrow; Emily G Lowery; Jon R Fee; Darin J Knapp; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

Review 5.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.